跳转至内容
Merck
所有图片(1)

主要文件

查看所有文档

H0537

Millipore

HIS-Select® HF 镍亲和凝胶

别名:

Ni-NTA HF resin

登录查看公司和协议定价
所有图片(1)

About This Item

UNSPSC代码:
41106500
NACRES:
NA.56

表单

suspension

质量水平

200

技术

affinity chromatography: suitable

基质

Highly cross-linked 6% Beaded Agarose

容量

15 mg/mL, gel binding capacity (protein)(with an approx. 30 kDa protein)

储存温度

2-8°C

相关类别

一般描述

HIS-Select 高流动性镍亲和凝胶是一种固定化金属离子亲和色谱（IMAC）凝胶，设计用于特异性结合色谱系统中的His-tag蛋白（含组氨酸蛋白质），压力高达 200 psi，最大线性流速为 3,000 cm/hr。

应用

亲和凝胶适用于在天然和变性条件下纯化组氨酸标记的蛋白质（His-tag蛋白）。
镍亲和凝胶用于纯化His-tag® 蛋白（组氨酸标记蛋白） 。 HIS-Select® 高流动性 (HF) 产品将HIS-Select 技术优良的选择性和高度交联的琼脂糖相结合，可在压力下实现更高的流速和机械稳定性。 HIS-Select HF产品设计用于生产规模的纯化和FPLC™ 应用。 和其他HIS-Select产品一样，次氮基三乙酸镍（Ni-NTA)）的螯合基团与琼脂糖的不带电亲水键可确保实现真正的一步纯化。

特点和优势

  • 高选择性确保了高纯度
  • 独特的不带电亲水键减少了非特异性结合
  • 组氨酸标记蛋白（His-tag蛋白）的结合能力大于 15 mg/mL
  • 高度交联的琼脂糖基质允许在更高压力下纯化
  • 在变性或非变性条件下结合
  • 一步纯化

外形

30% 乙醇溶液的混悬液 (1:1)

制备说明

使用前必须除去乙醇。用去离子水洗涤亲和凝胶以除去乙醇，然后用提供的平衡缓冲液进行平衡。

法律信息

FPLC is a trademark of Cytiva
HIS TAG is a registered trademark of Merck KGaA, Darmstadt, Germany
HIS-Select is a registered trademark of Merck KGaA, Darmstadt, Germany

警示用语：

Danger

危险分类

Acute Tox. 4 Oral - Aquatic Chronic 2 - Carc. 1A Inhalation - Flam. Liq. 3 - Muta. 2 - Repr. 1B - Resp. Sens. 1 - Skin Irrit. 2 - Skin Sens. 1 - STOT RE 1 - STOT SE 2

靶器官

Eyes,Central nervous system, Respiratory Tract

WGK

WGK 3

闪点(°F)

88.0 °F

闪点(°C)

31.1 °C

个人防护装备

Eyeshields, Faceshields, Gloves, type ABEK (EN14387) respirator filter

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number
SLCQ5051
SLCL9242
SLCG1131
SLCB1729
SLBR9492V

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Hesham Saeed et al.
International journal of biological macromolecules, 106, 1041-1051 (2017-08-31)
l-Asparaginase (EC 3.5.1.1) is an important medical enzyme that catalysis the hydrolysis of l-asparagine to aspartic acid and ammonium. For over four decades l. asparaginase utic agent for the treatment of a variety of lymphoproliferative disorders and lymphoma such as
Irving E Vega et al.
Frontiers in neuroscience, 13, 845-845 (2019-08-29)
The transition of tau proteins from its soluble physiological conformation to the pathological aggregate forms found in Alzheimer's disease and related dementias, is poorly understood. Therefore, understanding the process that modulates the formation of toxic tau oligomers and their conversion
David S Pitcher et al.
EBioMedicine, 2(7), 642-648 (2015-08-20)
The proteasome inhibitor Bortezomib is used to treat multiple myeloma (MM). Bortezomib inhibits protein degradation by inactivating proteasomes' active-sites. MM cells are exquisitely sensitive to Bortezomib - exhibiting a low-nanomolar IC(50) - suggesting that minimal inhibition of degradation suffices to
Minoru Tanaka et al.
Nature chemical biology, 12(12), 1089-1096 (2016-10-25)
Cellular signaling is often propagated by multivalent interactions. Multivalency creates avidity, allowing stable biophysical recognition. Multivalency is an attractive strategy for achieving potent binding to protein targets, as the affinity of bivalent ligands is often greater than the sum of
Finaritra Raoelijaona et al.
RNA biology, 15(9), 1174-1180 (2018-09-04)
Ribosome biogenesis requires a variety of trans-acting factors in order to produce functional ribosomal subunits. In human cells, the complex formed by the proteins hNob1 and hPno1 is crucial to the site 3 cleavage occurring at the 3'-end of 18S
查看所有相关文献

相关内容

蛋白质Pull-Down技术

利用亲和力、GST pull-down、TAP 和共免疫沉淀方法，通过Pull-Down研究体外蛋白质互作。

Protein Pull-Down Techniques

Investigate in vitro protein-protein interactions with pull-down assays, utilizing affinity, GST pull-down, TAP, and co-immunoprecipitation methods.

Protein Pull-Down Techniques

Investigate in vitro protein-protein interactions with pull-down assays, utilizing affinity, GST pull-down, TAP, and co-immunoprecipitation methods.

Protein Pull-Down Techniques

Investigate in vitro protein-protein interactions with pull-down assays, utilizing affinity, GST pull-down, TAP, and co-immunoprecipitation methods.

查看所有结果

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门